Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-04-11
2009-06-30
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S521000
Reexamination Certificate
active
07553833
ABSTRACT:
There are provided compounds of the general formulaswherein X, Y, R1, R2, R3, R4and R5are as described herein. The compounds exhibit anticancer activity.
REFERENCES:
patent: 0947511 (1999-10-01), None
Howard C. Ansel, Pharmaceutical Dosage Forms and Drug Delivery Systems, 6thEd. 1995, pp. 196, 456-457.
Lippa, B. et al,Bioorganic&Med. Chem. Letters, 18(11), (2008) 3359-3363 XP022711228.
Liu Jin-Jun
Tilley Jefferson Wright
Zhang Zhuming
Hoffmann-La Roche Inc.
Johnston George W.
Kifle Bruck
Rocha-Tramaloni Patricia S.
LandOfFree
3,3-spiroindolinone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3,3-spiroindolinone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3,3-spiroindolinone derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4073445